Tivic Health Systems, Inc. (VBIO)

Tivic Health Systems Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	-	-	1.18	1.84	1.26
Revenue Growth (YoY)	-	-	-36.09%	46.38%	46.16%
Cost of Revenue	-	-	0.89	1.54	1.3
Gross Profit	-	-	0.29	0.3	-0.04
Selling, General & Admin	4.77	3.16	6.88	8.67	4.72
Research & Development	3.13	1.31	1.66	1.73	0.88
Operating Income	-7.9	-4.48	-8.25	-10.1	-5.63
Interest Income	0.02	0.01	0	0	-
Interest Expense	-0.15	-	-	-	-1.82
Other Non-Operating Income (Expense)	0.03	-	-	-	-1.04
Total Non-Operating Income (Expense)	-0.1	0.01	0	0	-2.86
Pretax Income	-7.99	-4.47	-8.24	-10.1	-8.49
Net Income	-8.88	-5.66	-8.24	-10.1	-8.49
Earnings From Discontinued Operations	-0.89	-1.19	-	-	-
Net Income to Common	-8.88	-5.66	-8.24	-10.1	-8.49
Shares Outstanding (Basic)	1	0	0	0	0
Shares Outstanding (Diluted)	1	0	0	0	0
Shares Change (YoY)	302.10%	516.01%	163790.65%	177.04%	51.67%
EPS (Basic)	-7.84	-19.68	-176.80	-354688.00	-826200.00
EPS (Diluted)	-7.84	-19.68	-176.80	-354688.00	-826200.00
Shares Outstanding	2.76	0.56	0	0	0
Free Cash Flow	-7.04	-5.73	-8.63	-8.93	-5.61
Free Cash Flow Per Share	-6.09	-19.92	-184.97	-313728.00	-546216.00
Gross Margin	-	-	24.40%	16.25%	-3.02%
Operating Margin	-	-	-701.11%	-548.80%	-448.13%
Profit Margin	-	-	-701.02%	-548.70%	-675.74%
FCF Margin	-	-	-733.76%	-485.33%	-446.46%
EBITDA	-7.89	-4.47	-8.24	-10.09	-5.63
EBITDA Margin	-	-	-700.42%	-548.26%	-447.49%
EBIT	-7.9	-4.48	-8.25	-10.1	-5.63
EBIT Margin	-	-	-701.11%	-548.80%	-448.13%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.